<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
		>
<channel>
	<title>Comments on: Talking with Jamie Heywood about PatientsLikeMe</title>
	<atom:link href="http://blog.jonudell.net/2009/06/01/talking-with-jamie-heywood-about-patientslikeme/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.jonudell.net/2009/06/01/talking-with-jamie-heywood-about-patientslikeme/</link>
	<description>Strategies for Internet citizens</description>
	<lastBuildDate>Sun, 12 Feb 2012 18:22:41 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
	<item>
		<title>By: Four short links: 2 June 2009 &#124; Tech-monkey.info Blogs</title>
		<link>http://blog.jonudell.net/2009/06/01/talking-with-jamie-heywood-about-patientslikeme/#comment-127796</link>
		<dc:creator><![CDATA[Four short links: 2 June 2009 &#124; Tech-monkey.info Blogs]]></dc:creator>
		<pubDate>Tue, 02 Jun 2009 15:24:26 +0000</pubDate>
		<guid isPermaLink="false">http://blog.jonudell.net/?p=1562#comment-127796</guid>
		<description><![CDATA[[...] Talking With Jamie Heywood About PatientsLikeMe (Jon Udell) &#8212; the creator of patientslikeme, a site that provides people with serious conditions a chance to report on the efficacy of their treatment, their unique symptoms, and (if they wish) to connect with the researchers in the drug companies who made the treatments. It&#8217;s a new closure for the feedback loop of medical research. [...]]]></description>
		<content:encoded><![CDATA[<p>[...] Talking With Jamie Heywood About PatientsLikeMe (Jon Udell) &#8212; the creator of patientslikeme, a site that provides people with serious conditions a chance to report on the efficacy of their treatment, their unique symptoms, and (if they wish) to connect with the researchers in the drug companies who made the treatments. It&#8217;s a new closure for the feedback loop of medical research. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

